Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).
复制标题
DOI：
10.1002/cam4.3605
复制
发表时间：
2021-01
期刊：
影响因子：
4
通讯作者：
Fotopoulou C
中科院分区：
文献类型：
--
作者：
Gultekin M;Ak S;Ayhan A;Strojna A;Pletnev A;Fagotti A;Perrone AM;Erzeneoglu BE;Temiz BE;Lemley B;Soyak B;Hughes C;Cibula D;Haidopoulos D;Brennan D;Cola E;van der Steen-Banasik E;Urkmez E;Akilli H;Zapardiel I;Tóth I;Sehouli J;Zalewski K;Bahremand K;Chiva L;Mirza MR;Papageorgiou M;Zoltan N;Adámková P;Morice P;Garrido-Mallach S;Akgor U;Theodoulidis V;Arik Z;Steffensen KD;Fotopoulou C
尚未记录COVID-19大流行对正在接受积极治疗或随访的欧洲妇科癌症患者的影响。我们试图了解患者对COVID-19影响的看法以及全球范围内实施的治疗调整。在16个欧洲国家进行了一项患者调查，使用了由ENGAGe开发的新的COVID-19相关问卷和医院焦虑和抑郁量表问卷（HADS）。这项调查是由全国性的病人倡导组织和慈善组织推动的。我们收集了1388份表格; 592份在线表格和796份纸质表格（2020年5月）。我们排除了137个数据缺失的病例。患者的中位年龄为55岁（范围：18 - 89岁），54.7%患有卵巢癌，15.5%为术前患者。尽管73.2%的患者将癌症列为COVID-19的风险因素，但只有17.5%的患者更害怕COVID-19而不是癌症，高龄（> 70岁）是唯一的重要风险因素。总体而言，71%的人担心如果他们的治疗/随访被取消/推迟，癌症会进展。大多数患者（64%）按计划继续接受护理，但72.3%（n = 892）的患者表示，他们没有收到有关患者和工作人员的整体COVID-19感染率、治疗医院的检测或措施的信息。平均HADS焦虑和抑郁评分分别为8.8（范围：5.3 - 12）和8.1（范围：3.8 - 13.4）。多变量分析确定了高HADS抑郁评分，由于大流行而经历了护理调整，以及担心无法去看医生是患者焦虑的独立预测因素。由于COVID-19大流行相关的护理调整，妇科癌症患者对其疾病进展表示严重焦虑，并希望按计划进行治疗，尽管存在相关风险。医疗保健专业人员在危机时期做出影响患者护理的决定时应考虑到这一点，并制定改善患者沟通和教育的举措。欧洲的妇科癌症患者呼吁提高透明度，并继续提供高标准的肿瘤治疗，即使在COVID-19大流行等危机时期也是如此。
The impact of the COVID‐19 pandemic on European gynaecological cancer patients under active treatment or follow‐up has not been documented. We sought to capture the patient perceptions of the COVID‐19 implications and the worldwide imposed treatment modifications. A patient survey was conducted in 16 European countries, using a new COVID‐19‐related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations. We collected 1388 forms; 592 online and 796 hard‐copy (May, 2020). We excluded 137 due to missing data. Median patients’ age was 55 years (range: 18–89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID‐19, only 17.5% were more afraid of COVID‐19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow‐up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID‐19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3–12) and 8.1 (range: 3.8–13.4), respectively. Multivariate analysis identified high HADS‐depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients’ anxiety. Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID‐19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients’ communication and education. Gynaecological cancer patients in Europe appeal for more transparency and continuation of high standard oncologic care even in times of crisis like the COVID‐19 pandemic.
登录
查看更多内容
影响因子：
3
作者：
Desideri, Isacco;Pilleron, Sophie;Soto-Perez-de-Celis, Enrique
通讯作者：
Soto-Perez-de-Celis, Enrique
影响因子：
3.4
作者：
Nepogodiev, D.;Bhangu, A.
通讯作者：
Bhangu, A.
DOI：
10.1016/j.annonc.2020.05.009
发表时间：
2020-08-01
期刊：
Annals of oncology : official journal of the European Society for Medical Oncology
影响因子：
--
作者：
Sud, A;Jones, M E;Turnbull, C
通讯作者：
Turnbull, C
影响因子：
3.9
作者：
Wang, Yingmei;Zhang, Shiqian;Xue, Fengxia
通讯作者：
Xue, Fengxia
DOI：
10.1111/igc.0b013e3181c10c04
发表时间：
2010-01-01
影响因子：
4.8
作者：
Fotopoulou, Christina;Savvatis, Konstantinos;Sehouli, Jalid
通讯作者：
Sehouli, Jalid